Clinical Trial Update: Comparison of Deferasirox and Desferoxamine in Patients of β-Thalassemia Major With Iron Overload [NA]

View source ↗

Summary

A completed clinical trial comparing the iron chelators deferasirox and deferoxamine in patients with β-thalassemia major and iron overload.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thalassemia Major

Drugs mentioned

• Deferasirox (Deferasirox)
• Desferoxamine (deferoxamine)

Snippet

Sponsor: RESnTEC, Institute of Research | Conditions: Pateints of β-thalassemia Major With Iron Overload | NA | Status: COMPLETED